Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma -- Data Supplement - Supplemental Figures -- Proceedings of the National Academy of Sciences

Supplementary material for Purkey et al. (2001) Proc. Natl. Acad. Sci. USA 98 (10), 5566–5571. (10.1073/pnas.091431798)

Fig. 10.
HPLC trace of compound 13 in conjunction with traces of compounds 10–12, 14, and 15 (see Figs. 7–9, 11, and 12) demonstrate the range of retention times of the compound peaks evaluated in comparison with the nonoverlapping TTR peaks.